viloxazine
Selected indexed studies
- Viloxazine. (, 2012) [PMID:34542988]
- Viloxazine. (, 2006) [PMID:36701514]
- Viloxazine: Pediatric First Approval. (Paediatr Drugs, 2021) [PMID:34036533]
_Worker-drafted node — pending editorial review._
Connections
viloxazine is a side effect of
Sources
- Viloxazine. (2012) pubmed
- Viloxazine. (2006) pubmed
- Viloxazine: Pediatric First Approval. (2021) pubmed
- Viloxazine Extended-Release: A Review in Attention-Deficit/Hyperactivity Disorder in Adults. (2025) pubmed
- Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder. (2021) pubmed
- Extended-Release Viloxazine for the Treatment of Attention-Deficit Hyperactivity Disorder in School-Age Children and Adolescents. (2023) pubmed
- Response Trajectories and Temporal Trends of Viloxazine Treatment for Young People With ADHD: A Meta-Analysis. (2024) pubmed
- Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents. (2024) pubmed
- Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status. (2021) pubmed
- Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients. (2023) pubmed